Literature DB >> 17691296

Deep brain stimulation for neuropathic pain.

S L F Owen1, A L Green, D D Nandi, R G Bittar, S Wang, T Z Aziz.   

Abstract

Deep brain stimulation (DBS) for pain was one of the earliest indications for the therapy. This study reports the outcome of DBS of the sensory thalamus and the periventricular and peri-aqueductal grey area (PVG/PAG) complex for different intractable neuropathic pain syndromes. Forty-seven patients (30 males and 17 females) were selected for surgery; they were suffering from any of the following types of pain: post-stroke neuropathic pain, phantom limb pain, post-herpetic neuralgia, anaesthesia dolorosa, brachial plexus injury and neuropathic pain secondary to neural damage from a variety of causes. Of the 47 patients selected for trial stimulation, 38 patients proceeded to permanent implantation. Patients suffering from post-stroke pain were the most likely to fail trial stimulation (33%), in contrast to individuals with phantom limb/post-brachial plexus injury pain and anaesthesia dolorosa, all of whom underwent permanent implantation. PVG stimulation alone was optimal in 17 patients (53%), whilst a combination of PVG and thalamic stimulation produced the greatest degree of analgesia in 11 patients (34%). Thalamic stimulation alone was optimal in 4 patients (13%). DBS of the PVG alone was associated with the highest degree of pain alleviation, with a mean improvement of 59% (p <0.001) and a > or =50% improvement in 66% of patients. Post-stroke pain responds in 70% of patients. We conclude that the outcomes of surgery appear to vary according to aetiology, but it would appear that the effects are best for phantom limb syndromes, head pain and anaesthesia dolorosa.

Entities:  

Mesh:

Year:  2007        PMID: 17691296     DOI: 10.1007/978-3-211-33081-4_13

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  20 in total

Review 1.  Invasive brain stimulation for the treatment of neuropathic pain.

Authors:  Jean-Paul Nguyen; Julien Nizard; Yves Keravel; Jean-Pascal Lefaucheur
Journal:  Nat Rev Neurol       Date:  2011-09-20       Impact factor: 42.937

2.  Deep brain stimulation complicated by bilateral large cystic cavitation around the leads in a patient with Parkinson's disease.

Authors:  Jonathan Jagid; Karthik Madhavan; Amade Bregy; Mehul Desai; Armando Ruiz; Robert Quencer; Howard J Landy
Journal:  BMJ Case Rep       Date:  2015-10-16

3.  The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Ana Vicente-Sánchez; Esther Berrocoso; Javier Garzón
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

Review 4.  Auditory midbrain implant: a review.

Authors:  Hubert H Lim; Minoo Lenarz; Thomas Lenarz
Journal:  Trends Amplif       Date:  2009-09

Review 5.  Deep Brain Stimulation for Chronic Pain.

Authors:  Steven M Falowski
Journal:  Curr Pain Headache Rep       Date:  2015-07

Review 6.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

Review 7.  Neuropathic pain and deep brain stimulation.

Authors:  Erlick A C Pereira; Tipu Z Aziz
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

Review 8.  Neuromodulation for brain disorders: challenges and opportunities.

Authors:  Matthew D Johnson; Hubert H Lim; Theoden I Netoff; Allison T Connolly; Nessa Johnson; Abhrajeet Roy; Abbey Holt; Kelvin O Lim; James R Carey; Jerrold L Vitek; Bin He
Journal:  IEEE Trans Biomed Eng       Date:  2013-02-01       Impact factor: 4.538

9.  Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling.

Authors:  Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Javier Garzón
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

10.  The nucleus accumbens as a potential target for central poststroke pain.

Authors:  Grant W Mallory; Osama Abulseoud; Sun-Chul Hwang; Deborah A Gorman; Squire M Stead; Bryan T Klassen; Paola Sandroni; James C Watson; Kendall H Lee
Journal:  Mayo Clin Proc       Date:  2012-09-12       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.